Genus PLC shares fell sharply after the British animal genetics group published preliminary results for the fiscal year 2026. The stock declined 6.5% to trade at 2088p following the release, as investors digested a mixed set of numbers and a cautious near-term earnings outlook.
Top-line and drivers
For the fiscal year, Genus reported adjusted revenue of £658.1 million, a 2% decline versus the prior year and below the analyst consensus of £668.28 million. The company attributed much of the top-line contraction to the deconsolidation of PIC China - its Chinese porcine genetics unit - which was moved into a new joint venture with Beijing Capital Agribusiness.
Profitability
On the profitability front, Genus posted a stronger performance. Adjusted operating profit, including results from joint ventures, rose by 25% to £116.0 million. The gain was driven by robust growth at PIC and was supported by a £5.6 million milestone payment from Beijing Capital Agribusiness. Adjusted profit before tax increased 35% to £100.2 million.
Outlook and near-term risks
Management provided cautious guidance for fiscal 2027, saying adjusted profit before tax is expected to be weighted to the second half. The company pointed to several first-half headwinds that underpin this guidance: disease-related challenges affecting North American pork production, weak pork prices in Brazil, and subdued global dairy prices. These factors, it said, will likely depress earnings in the first half of FY27 relative to the second half.
Shareholder return action
Genus also announced a £60 million share buyback programme alongside the results. While the buyback is shareholder-friendly, it did not prevent the market reaction to the revenue shortfall and the conservative FY27 guidance; shares remained well below the intraday peak of 2362p reached earlier in the session.
Market context
The stock moved in a wider UK market environment that had opened against a challenging global backdrop. On Thursday, September 10, London equities were attempting a modest recovery after an earlier sell-off, with investors weighing the effects of rising oil prices, tensions in the Middle East, and renewed inflation concerns. In the prior session, the FTSE 100 had fallen 1.31% and the FTSE 250 dropped 0.99% as Brent crude climbed above $100 a barrel for the first time since July, heightening worries that energy costs could keep inflation elevated and complicate central bank decisions.
Why the stock fell
Investors reacted negatively to the combination of a revenue miss versus consensus, a forward profit outlook leaning on the second half of the year, and an uncertain macro backdrop for UK mid-cap names. Even with record adjusted profits and a material buyback announced, these elements were sufficient to drive a sharp intraday decline in Genus shares, taking the price down from the session high to the level around 2088p at the time of reporting.
Bottom line
Genus reported stronger-than-expected adjusted profits for FY26 but failed to meet revenue expectations after PIC China was deconsolidated into a joint venture. Management signalled that FY27 profits will likely be second-half weighted because of livestock disease in North America, low Brazilian pork prices, and weak global dairy prices. A £60 million buyback was disclosed but did not offset investor concerns, and the stock moved notably lower in a broader market dealing with higher oil prices and geopolitical and inflation-related uncertainties.